Cargando…
Population Pharmacokinetics of Amikacin in Patients on Veno-Arterial Extracorporeal Membrane Oxygenation
Veno-arterial extracorporeal membrane oxygenation (V-A ECMO) support leads to complex pharmacokinetic alterations, whereas adequate drug dosing is paramount for efficacy and absence of toxicity in critically ill patients. Amikacin is a major antibiotic used in nosocomial sepsis, especially for these...
Autores principales: | Pressiat, Claire, Kudela, Agathe, De Roux, Quentin, Khoudour, Nihel, Alessandri, Claire, Haouache, Hakim, Vodovar, Dominique, Woerther, Paul-Louis, Hutin, Alice, Ghaleh, Bijan, Hulin, Anne, Mongardon, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879580/ https://www.ncbi.nlm.nih.gov/pubmed/35214022 http://dx.doi.org/10.3390/pharmaceutics14020289 |
Ejemplares similares
-
Impaired Pharmacokinetics of Amiodarone under Veno-Venous Extracorporeal Membrane Oxygenation: From Bench to Bedside
por: Lescroart, Mickaël, et al.
Publicado: (2022) -
Amikacin Pharmacokinetics During Continuous Veno-Venous Hemodialysis
por: Lam, Simon W., et al.
Publicado: (2013) -
Early Coronary Reperfusion Facilitates Return of Spontaneous Circulation and Improves Cardiovascular Outcomes After Ischemic Cardiac Arrest and Extracorporeal Resuscitation in Pigs
por: Hutin, Alice, et al.
Publicado: (2016) -
Diagnostic yield of routine daily blood culture in patients on veno-arterial extracorporeal membrane oxygenation
por: de Roux, Quentin, et al.
Publicado: (2021) -
Argon Attenuates Multiorgan Failure in Relation with HMGB1 Inhibition
por: de Roux, Quentin, et al.
Publicado: (2021)